Health regulator approves MSD’s oral Covid-19 drug in Brazil
The Brazilian Health Regulatory Agency (Anvisa) approved, after a meeting on Wednesday, the emergency use of the drug molnupiravir, produced by U.S-based pharmaceutical company Merck Sharp & Dohme (MSD), effective against Covid-19. MSD told Valor that the drug showed 89% efficacy against deaths in infected patients who started treatment up to five days after the […]
